loading

Neurocrine Biosciences Inc Borsa (NBIX) Ultime notizie

pulisher
06:26 AM

Measuring Neurocrine Biosciences Inc.’s beta against major indices2025 Price Momentum & Scalable Portfolio Growth Ideas - newser.com

06:26 AM
pulisher
02:32 AM

What RSI levels show for Neurocrine Biosciences Inc. (NB3) stockJuly 2025 Breakouts & Reliable Price Breakout Alerts - newser.com

02:32 AM
pulisher
02:15 AM

How Neurocrine Biosciences Inc. stock responds to policy changesDay Trade & Weekly Market Pulse Updates - newser.com

02:15 AM
pulisher
01:04 AM

Can Neurocrine Biosciences Inc. (NB3) stock beat analyst consensus2025 Big Picture & Free Safe Capital Growth Stock Tips - newser.com

01:04 AM
pulisher
Nov 15, 2025

What makes Neurocrine Biosciences Inc. (NB3) stock appealing to growth investorsJuly 2025 Drop Watch & Comprehensive Market Scan Insights - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Is Neurocrine Biosciences Inc. (NB3) stock attractive for dividend growthQuarterly Market Summary & Verified Swing Trading Watchlist - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Can Neurocrine Biosciences Inc. stock weather global recessionWeekly Trade Recap & High Return Trade Opportunity Guides - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Why Neurocrine Biosciences Inc. stock remains resilientInflation Watch & Community Shared Stock Ideas - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Is Neurocrine Biosciences Inc. (NB3) stock a buy for dividend portfolios2025 Big Picture & Technical Entry and Exit Alerts - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Is Neurocrine Biosciences Inc. stock trading near support levels2025 Market Outlook & Daily Stock Trend Watchlist - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

Why Neurocrine Biosciences Inc. (NB3) stock could rally stronglyJuly 2025 Fed Impact & Low Drawdown Investment Strategies - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

What valuation multiples suggest for Neurocrine Biosciences Inc. stockJuly 2025 Final Week & Free Community Consensus Stock Picks - newser.com

Nov 14, 2025
pulisher
Nov 13, 2025

Will Neurocrine Biosciences Inc. (NB3) stock boost dividends furtherPortfolio Value Report & Real-Time Volume Analysis Alerts - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

Is it time to cut losses on Neurocrine Biosciences Inc.Weekly Trend Recap & Technical Confirmation Alerts - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

What data driven models say about Neurocrine Biosciences Inc.’s futureJobs Report & Smart Swing Trading Alerts - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

How to build a dashboard for Neurocrine Biosciences Inc. stockWeekly Market Summary & Expert Approved Momentum Ideas - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

What earnings revisions data tells us about Neurocrine Biosciences Inc.Quarterly Risk Review & Expert Curated Trade Setup Alerts - newser.com

Nov 13, 2025
pulisher
Nov 12, 2025

Assessing Neurocrine Biosciences (NBIX) Valuation After Recent Share Price Momentum - Yahoo Finance

Nov 12, 2025
pulisher
Nov 12, 2025

What analysts say about Neurocrine Biosciences Inc stockPrice Volatility Patterns & Small Budget Growth - earlytimes.in

Nov 12, 2025
pulisher
Nov 12, 2025

Neurocrine Biosciences to Present at Upcoming Investor Conferences - Your Wyoming Link

Nov 12, 2025
pulisher
Nov 12, 2025

Assessing Neurocrine Biosciences After Stock Rises 7.8% and Partnership Expansion News - Yahoo Finance

Nov 12, 2025
pulisher
Nov 12, 2025

What analysts say about Neurocrine Biosciences Inc NB3 stockSector Performance Review & Free Turn Volatility To Profit - earlytimes.in

Nov 12, 2025
pulisher
Nov 12, 2025

Neurocrine’s depression candidate fails mid-stage study but analysis continues - The Pharma Letter

Nov 12, 2025
pulisher
Nov 12, 2025

Neurocrine Biosciences (NBIX): Assessing Valuation After Lead Depression Drug Misses Phase 2 Study Goal - simplywall.st

Nov 12, 2025
$10.72
price down icon 1.74%
drug_manufacturers_specialty_generic RDY
$13.94
price up icon 0.50%
$21.09
price down icon 4.09%
$36.98
price up icon 2.58%
$466.40
price up icon 0.89%
Capitalizzazione:     |  Volume (24 ore):